谷氨酸-氨酸转胺酶1缺乏的代谢重编程有助于结直肠腺瘤-结直肠癌的进展
Li Xiong1,2,3, Xin Yang1,2,3, Huashan Liu1,2,3
1Department of Colorectal Surgery (General Surgery), Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
Science translational medicine
|January 1, 2025
概括
谷氨基-酸转氨酶1 (GPT1) 通过重编程新陈代谢和抑制WNT信号传递来抑制结肠直肠癌 (CRC). 聚胺激活GPT1为预防和治疗CRC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 结肠直肠癌 (CRC) 瘤发生遵循一个正常-腺瘤-癌瘤 (N-A-C) 序列.
- 结直肠腺瘤致癌的分子机制尚未完全理解.
研究的目的:
- 为了研究谷氨酸-氨酸转胺酶1 (GPT1) 在结肠直肠癌 (CRC) 进展中的作用.
- 确定向CRC中的GPT1的分子机制和潜在的治疗剂.
主要方法:
- 正常,腺瘤和癌瘤组织的转录形状分析.
- 通过克鲁佩尔类因子4 (KLF4) 分析GPT1调节.
- 在体外和体内研究使用细胞系,器官和患者衍生异种移植 (PDX) 模型.
主要成果:
- 在CRC进展过程中,GPT1的下调,与预后不佳相关.
- KLF4通过转录激活了GPT1.1.
- 通过调节新陈代谢 (α-甲酸盐的产生),抑制WNT信号传递,并通过MTHFD1L相互作用破坏叶酸循环,GPT1抑制CRC.
- 在临床前模型中,聚胺激活了GPT1并抑制了CRC的进展.
结论:
- 通过多方面的机制,GPT1在抑制CRC瘤发生方面发挥着关键作用.
- 聚胺通过激活GPT1.1,表明其作为预防和治疗CRC的治疗剂的潜力.
相关概念视频
Inborn Errors of Metabolism
106
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
106
Tumor Progression
6.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.0K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K


